Azitra AZTR
NYSE AZTR
$0.13 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Azitra (AZTR) Gains from Sales and Divestitures (2022 - 2025)

Updated

Azitra's Gains from Sales and Divestitures was -$2,069 in FY2025, compared with -$4,859 in FY2024.

Analysis

Azitra (AZTR) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends

From FY2022 onward, Azitra has reported Gains from Sales and Divestitures for 4 years.

  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$4,859 in FY2024, -$41,417 in FY2023 and -$7,923 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Azitra 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -3,244.00
Mar 31, 2025 1,175.00
Sep 30, 2024 -4,859.00
Sep 30, 2023 -41,417.00
Sep 30, 2022 -7,923.00
API Access

Azitra Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AZTR&period=max&api_key=YOUR_API_KEY